Quick answers
- What is Potassium chloride, dextrose monohydrate used for?
- The FDA-approved label (Potassium Chloride in Dextrose, ICU Medical Inc., October 30, 2025) says: “This solution is indicated in patients requiring parenteral administration of potassium chloride with minimal carbohydrate calories.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Potassium chloride, dextrose monohydrate have a boxed warning?
- No. None of the 3 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Potassium chloride, dextrose monohydrate?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Potassium chloride, dextrose monohydrate been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Potassium chloride, dextrose monohydrate?
- 3 companies list prescription products of Potassium chloride, dextrose monohydrate in the FDA NDC Directory, including Fresenius Kabi USA, LLC, ICU Medical Inc. and Baxter Healthcare Company.
What Potassium chloride, dextrose monohydrate is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
This solution is indicated in patients requiring parenteral administration of potassium chloride with minimal carbohydrate calories.
— FDA label: Potassium Chloride in Dextrose, ICU Medical Inc., effective October 30, 2025. Read the full label on DailyMed →
The FDA has 3 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 3 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Injection, solution |
|---|---|
| Route | Intravenous |
| Prescription products | 4 in the FDA NDC Directory |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Fresenius Kabi USA, LLC2 products
- ICU Medical Inc.1 product
- Baxter Healthcare Company1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA017634 DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER, DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER, DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER, DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER | Baxter Hlthcare | February 1, 1979 | 55, latest July 15, 2019 2019: Labeling · 2017: Labeling · 2017: Labeling |
| NDA018371 POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER | Otsuka Icu Medcl | May 29, 1980 | 62, latest September 8, 2014 2014: Manufacturing (CMC) · 2001: Manufacturing (CMC) · 1999: Labeling |
Generic approvals (1)
- ANDA212346Fresenius Kabi USA · September 10, 2020
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 309783, 2566844 |
|---|---|
| SPL set ID of the quoted label | 02d694b5-3600-4d55-bd5c-924abaec5315 |
| FDA labels (SPL) | 3 |
| FDA applications | NDA017634, NDA018371, 1 ANDA |
| Active ingredients (FDA) | DEXTROSE MONOHYDRATE / POTASSIUM CHLORIDE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Potassium Chloride in Dextrose, ICU Medical Inc., effective October 30, 2025; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →